Bausch Health reports Q3 2022 results; exhibit with details not provided

Bausch Health Companies Inc.

2022-Q3 EPS reported $0.51 revenue$5,931,000,000

Company issued a press release for Q3 2022 results on November 3, 2022.
Press release attached as Exhibit 99.1 but full text not included in the provided content.
No specific financial figures, guidance, or segment details available for summary.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Bausch Health Companies Inc. reported financial results for the quarter ended September 30, 2022.

Period: the quarter ended September 30, 2022
Result: reported results

Exact text from the filing

On November 3, 2022, Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2022 and certain other financial information as of and for the quarter ended September 30, 2022. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference.

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-22-000058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.